Oramed CEO Nadav Kidron on CNBC: Oral insulin to be a gamechanger
Oral insulin to be a game changer: Oramed CEO Nadav Kidron tells CNBC On Squawk Box Asia, Kidron talks about the company’s latest offering
Oral insulin to be a game changer: Oramed CEO Nadav Kidron tells CNBC On Squawk Box Asia, Kidron talks about the company’s latest offering
